Neelanjana Shefali Champa Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Year, 9 Months
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 4.32 M
- Revenue Growth -4.43%
- Profit Growth -30.56%
- Ebitda -69.02%
- Net Worth 47.18%
- Total Assets 83.82%
About Neelanjana Shefali Champa Healthcare
Neelanjana Shefali Champa Healthcare Private Limited (NSCHPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 May 2016 (Eight years and nine months 11 days old ). Its registered office is in Kamrup, Assam, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹4.32 M.
Champabati Barman and Samir Barman serve as directors at the Company.
Company Details
- Location
Kamrup, Assam, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51507AS2016PTC017417
- Company No.
017417
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 May 2016
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Shillong
Industry
Who are the key members and board of directors at Neelanjana Shefali Champa Healthcare?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Champabati Barman  | Director | 17-May-2016 | Current |
| Samir Barman | Director | 17-May-2016 | Current |
Financial Performance of Neelanjana Shefali Champa Healthcare.
Neelanjana Shefali Champa Healthcare Private Limited, for the financial year ended 2020, experienced Minor drop in revenue, with a 4.43% decrease. The company also saw a substantial fall in profitability, with a 30.56% decrease in profit. The company's net worth Soared by an impressive increase of 47.18%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Neelanjana Shefali Champa Healthcare?
In 2018, Neelanjana Shefali Champa Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹4.32 M
₹0
Charges Breakdown by Lending Institutions
- Uco Bank : 0.43 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Jun 2020 | Uco Bank | ₹0.47 M | Open |
| 05 May 2020 | Uco Bank | ₹0.35 M | Open |
| 26 Mar 2018 | Uco Bank | ₹3.50 M | Open |
How Many Employees Work at Neelanjana Shefali Champa Healthcare?
Unlock and access historical data on people associated with Neelanjana Shefali Champa Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Neelanjana Shefali Champa Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neelanjana Shefali Champa Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.